Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9735 |
High Similarity |
NPD3882 |
Suspended |
0.9474 |
High Similarity |
NPD2801 |
Approved |
0.9032 |
High Similarity |
NPD1934 |
Approved |
0.9013 |
High Similarity |
NPD1512 |
Approved |
0.8917 |
High Similarity |
NPD3817 |
Phase 2 |
0.8882 |
High Similarity |
NPD1511 |
Approved |
0.8854 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8834 |
High Similarity |
NPD3818 |
Discontinued |
0.8827 |
High Similarity |
NPD6166 |
Phase 2 |
0.8827 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8827 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8795 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8696 |
High Similarity |
NPD5494 |
Approved |
0.8642 |
High Similarity |
NPD1247 |
Approved |
0.8636 |
High Similarity |
NPD6799 |
Approved |
0.8581 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8563 |
High Similarity |
NPD6797 |
Phase 2 |
0.8512 |
High Similarity |
NPD7251 |
Discontinued |
0.8462 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8457 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8447 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8443 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8424 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.8395 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8393 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8393 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8385 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8313 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8293 |
Intermediate Similarity |
NPD919 |
Approved |
0.8212 |
Intermediate Similarity |
NPD943 |
Approved |
0.8212 |
Intermediate Similarity |
NPD1240 |
Approved |
0.821 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8199 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8194 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8144 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8129 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8129 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8129 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8117 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8107 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8105 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8065 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8049 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8012 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8012 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8012 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7949 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7939 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7922 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7922 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7911 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7901 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7888 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7874 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7848 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7818 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7812 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7798 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7785 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7784 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7778 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7778 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7746 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7722 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7712 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7683 |
Intermediate Similarity |
NPD920 |
Approved |
0.7662 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7661 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7647 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7647 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.764 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7628 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7628 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7616 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7613 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7593 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7582 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7569 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7561 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7558 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7544 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7531 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7531 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.753 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7529 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7529 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7469 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7459 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7439 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7416 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7403 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7401 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7394 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7353 |
Intermediate Similarity |
NPD37 |
Approved |
0.7346 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7345 |
Intermediate Similarity |
NPD2163 |
Approved |
0.7342 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7329 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7326 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7326 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7326 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.732 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7312 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7289 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7284 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7284 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7278 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7278 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7261 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7256 |
Intermediate Similarity |
NPD2654 |
Approved |
0.725 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.725 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7247 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7239 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7234 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7216 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7216 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7211 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7211 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7211 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7211 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7211 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7211 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7211 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7208 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7193 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7193 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7188 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.717 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7169 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7168 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7152 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7151 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7108 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7081 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7081 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7069 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7063 |
Intermediate Similarity |
NPD411 |
Approved |
0.7059 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7044 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7044 |
Intermediate Similarity |
NPD7907 |
Approved |
0.7039 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7032 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7032 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7025 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7022 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7012 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7011 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7011 |
Intermediate Similarity |
NPD8312 |
Approved |
0.701 |
Intermediate Similarity |
NPD7698 |
Approved |
0.701 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.701 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.6995 |
Remote Similarity |
NPD2494 |
Approved |
0.6995 |
Remote Similarity |
NPD2493 |
Approved |
0.6993 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.6987 |
Remote Similarity |
NPD1608 |
Approved |
0.6981 |
Remote Similarity |
NPD2861 |
Phase 2 |
0.6978 |
Remote Similarity |
NPD1729 |
Discontinued |
0.6974 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6974 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.697 |
Remote Similarity |
NPD7874 |
Approved |
0.697 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6964 |
Remote Similarity |
NPD3887 |
Approved |
0.6957 |
Remote Similarity |
NPD3764 |
Approved |
0.6957 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD3268 |
Approved |
0.6954 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6947 |
Remote Similarity |
NPD6534 |
Approved |
0.6947 |
Remote Similarity |
NPD6535 |
Approved |
0.6946 |
Remote Similarity |
NPD2899 |
Discontinued |
0.6946 |
Remote Similarity |
NPD4111 |
Phase 1 |
0.6946 |
Remote Similarity |
NPD4665 |
Approved |
0.6944 |
Remote Similarity |
NPD4575 |
Clinical (unspecified phase) |
0.6943 |
Remote Similarity |
NPD2982 |
Phase 2 |
0.6943 |
Remote Similarity |
NPD2983 |
Phase 2 |
0.6941 |
Remote Similarity |
NPD3146 |
Approved |
0.6941 |
Remote Similarity |
NPD3688 |
Clinical (unspecified phase) |
0.6941 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6941 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6932 |
Remote Similarity |
NPD5019 |
Clinical (unspecified phase) |
0.6928
|
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |